Sequenom Biosciences (India) Private Limited - Due diligence report

A 360° intelligence report on Sequenom Biosciences (India) Private Limited: trust score, financial health, credit view, compliance, director…

2007-04-23 New Delhi, Delhi Dissolved (Liquidated) Unlisted Active Compliant
Share
SB Sequenom Biosciences (India) Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sequenom Biosciences (India) Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
58/100
Trust Score
Moderate

Sequenom Biosciences (India) Private Limited is assessed as Moderate with a Trust Score of 58/100. Sequenom Biosciences (India) Private Limited is a private limited indian non-government company incorporated in 2007, operating in the Travel and Hospitality sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Sequenom Biosciences (India) Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
58/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 30/100 Caution Indicated
  • Company status is "Dissolved (Liquidated)" - not Active.
  • Last balance sheet is for Mar 2020 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SHEKHAR SONU DAWKHAR 01234567 Director 01/04/2018 6 yrs Approved
SHIVAKUMAR SHANKARAN 01234567 Director 01/04/2018 6 yrs Approved
KATHRYN MEI LUN TOM RUTKOWSKI 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Sequenom Inc (usa)
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Sequenom Inc (usa) Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 19+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Dissolved (Liquidated).
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence46/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment45/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view32/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
22 Sep 2020
Director ceased
SHEKHAR SONU DAWKHAR
Director ceased
SHIVAKUMAR SHANKARAN
Last AGM held
Annual general meeting
31 Aug 2020
Director appointed
SHIVAKUMAR SHANKARAN (Director)
31 Mar 2020
Latest balance sheet
Filed with ROC
06 Dec 2019
Director appointed
SHEKHAR SONU DAWKHAR (Director)
30 Sep 2019
Director ceased
PRASANNA MANJUNATH BHAT
30 Aug 2019
Director ceased
SANISH DAVIS
10 Jan 2019
Director ceased
ROBERT STEWART PRINGLE
30 Sep 2017
Director ceased
ROBERT JAMES DAVIE
15 May 2017
Director ceased
ALEXANDER MICHAEL MONKO
Director ceased
CAROLYN DIANNE BEAVER
Director ceased
PAUL VICTOR MAIER
30 Sep 2015
Director ceased
KATHRYN MEI LUN TOM RUTKOWSKI
29 Sep 2015
Director appointed
KATHRYN MEI LUN TOM RUTKOWSKI (Director)
10

Key Observations

Auto-generated from the data above
3 active director(s) / partner(s); board looks stable and experienced.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vaibhav Research Center And Care Private Limited U74999BR2016PTC031497 Phulwari, Bihar, India
Dhruva Industrial Consultants Private Limited U74900TG2014PTC092355 Qutubullapur, Telangana, India
Greenla Bioenergy And Plantation Private Limited U74999DL2012PTC233394 New Delhi, Delhi, India
Sg Artheart Private Limited U33110DL2013PTC256401 New Delhi, Delhi, India
Kirnd Institute Of Research & Development Private Limited U73100TN2015PTC102765 Trichy, Tamil Nadu, India
Jamuna Das Hospital And Research Centre Private Limited U85110DL1996PTC083409 Delhi, Delhi, India
Progressive Therapies Private Limited U52310DL2010PTC205107 New Delhi, Delhi, India
Sci - Molecules India Private Limited U73100PN2001PTC015987 Datta Mandir Pune, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sequenom Biosciences (India) Private Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sequenom Biosciences (India) Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Sequenom Biosciences (India) Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 58/100, distress signals and MSME payment-delay disclosures - know whether Sequenom Biosciences (India) Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sequenom Biosciences (India) Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sequenom Biosciences (India) Private Limited an active company?

Sequenom Biosciences (India) Private Limited has MCA status “Dissolved (Liquidated)” with a compliance score of 30/100 (Caution Indicated).

Is Sequenom Biosciences (India) Private Limited financially healthy?

Sequenom Biosciences (India) Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Sequenom Biosciences (India) Private Limited?

Its overall Trust Score is 58/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sequenom Biosciences (India) Private Limited?

The ultimate holding entity is Sequenom Inc (usa). 3 active director(s) are on record.

Does Sequenom Biosciences (India) Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Sequenom Biosciences (India) Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Sequenom Biosciences (India) Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.